20 Apr

TRIPS covid vaccine IP waiver proposal fails to address crucial questions

Because the proposed TRIPS waiver provides no means of spreading access to the trade secrets and know-how critical to the manufacture of covid-19 vaccines, it is not the solution many claim it to be

Adam Houldsworth

Author | Life sciences reporter

[email protected]

Adam Houldsworth